TRPC1 and Parkinson disease: It is evidenced that NMSAL, a derivative of Salsolinol, was found to be more noxious, perceived in the nigrostriatal and intraventricular fluid samples of PD patients, and displayed identical events to those of Salsolinol in the expression and localization of TRPC1, which specifies a defensive role for TRPC1 in PD.